Evidence-Based Reviews

Beyond threats: Risk factors for suicide in borderline personality disorder

Current Psychiatry. 2009 May;8(5):33-41

References

1. American Psychiatric Association. Practice guideline for the treatment of patients with borderline personality disorder. Am J Psychiatry. 2001;158(suppl 10):1-52.

2. Zanarini MC, Frankenburg FR, Hennen J, et al. The McLean study of adult development: overview and implications of the first six years of prospective follow-up. J Personal Disord. 2005;19(5):505-523.

3. Paris J. Chronic suicidality among patients with borderline personality disorder. Psychiatr Serv. 2002;53(6):738-742.

4. Diagnostic and statistical manual of mental disorders, 4th ed, text rev. Washington DC: American Psychiatric Association; 2000.

5. O’Carroll PW, Berman AL, Maris RW, et al. Beyond the Tower of Babel: a nomenclature for suicidology. Suicide Life Threat Behav. 1996;26(3):237-252.

6. Miller AL, Rathus JH, Linehan MM. Dialectical behavior therapy with suicidal adolescents. New York, NY: Guilford; 2007.

7. Brown MZ, Comtois KA, Linehan MM. Reasons for suicide attempts and nonsuicidal self-injury in women with borderline personality disorder. J Abnorm Psychol. 2002;111(1):198-202.

8. Berk MS, Jeglic E, Brown GK, et al. Characteristics of recent suicide attempters with and without borderline personality disorder. Arch Suicide Res. 2007;11(1):91-104.

9. Soloff PH, Lynch KG, Kelly TM, et al. Characteristics of suicide attempts of patients with major depressive episode and borderline personality disorder: a comparative study. Am J Psychiatry. 2000;157(4):601-608.

10. Paris J, Nowlis D, Brown R. Predictors of suicide in borderline personality disorder. Can J Psychiatry. 1989;34(1):8-9.

11. Paris J. Completed suicide in borderline personality disorder. Psychiatr Ann. 1990;20:19-21.

12. Soloff PH, Fabio A. Prospective predictors of suicide attempts in borderline personality disorder at one, two, and two-to-five year follow-up. J Personal Disord. 2008;22(2):123-134.

13. Oldham JM. Borderline personality disorder and suicidality. Am J Psychiatry. 2006;163(1):20-26.

14. Black DW, Blum N, Pfohl B, et al. Suicidal behavior in borderline personality disorder: prevalence, risk factors, prediction, and prevention. J Personal Disord. 2004;18(3):226-239.

15. Kolla NJ, Eisenberg H, Links PS. Epidemiology, risk factors, and psychopharmacological management of suicidal behavior in borderline personality disorder. Arch Suicide Res. 2008;12(1):1-19.

16. McGirr A, Paris J, Lesage A. Risk factors for suicide completion in borderline personality disorder: a case control study of cluster B comorbidity and impulsive aggression. J Clin Psychiatry. 2007;68:721-729.

17. Mann JJ, Apter A, Bertolote J, et al. Suicide prevention strategies: a systematic review. JAMA. 2005;294(16):2064-2074.

18. Linehan MM. Cognitive-behavioral treatment of borderline personality disorder. New York, NY: Guilford Press; 1993.

19. Berk MS, Henriques GR, Warman DM, et al. Cognitive therapy for suicide attempters: overview of the treatment and case examples. Cogn Behav Pract. 2004;11:265-277.

20. Wenzel A, Brown GK, Beck AT. Cognitive therapy for suicidal patients: scientific and clinical applications. Washington, DC: APA Books; 2008.

21. Linehan MM, Armstrong HE, Suarez A, et al. Cognitive behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry. 1991;48(12):1060-1064.

22. Linehan MM, Comtois KA, Murray AM, et al. Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry. 2006;63(7):757-766.

23. Beck AT, Steer RA, Brown GK. The Beck Depression Inventory, 2nd ed. San Antonio, TX: Psychological Corporation; 1996.

24. Paris J. Is hospitalization useful for suicidal patients with borderline personality disorder? J Personal Disord. 2004;18(3):240-247.

25. Clarkin JF, Levy KN, Lenzenweger MF, et al. Evaluating three treatments for borderline personality disorder: a multiwave study. Am J Psychiatry. 2007;164(6):1-7.

26. Bateman A, Fonagy P. Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatry. 1999;156(10):1563-1569.

27. Brown GK, Newman CF, Charlesworth SE, et al. An open clinical trial of cognitive therapy for borderline personality disorder. J Personal Disord. 2004;18(3):257-271.

28. Brown GK, Tenhave T, Henriques GR, et al. Cognitive therapy for the prevention of suicide attempts: a randomized controlled trial. JAMA. 2005;294(5):563-570.

29. Benedetti F, Sforzini L, Colombo C, et al. Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder. J Clin Psychiatry. 1998;59(3):103-107.

30. Chengappa KN, Ebeling T, Kang JS, et al. Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. J Clin Psychiatry. 1999;60(7):477-484.

31. Schulz SC, Camlin KL, Berry SA, et al. Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia. Biol Psychiatry. 1999;15;46(10):1429-1435.

32. Rocca P, Marchiaro L, Cocuzza E, et al. Treatment of borderline personality disorder with risperidone. J Clin Psychiatry. 2002;63(3):241-244.

33. Nickel MK, Muehlbacher M, Nickel C, et al. Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study. Am J Psychiatry. 2006;163(5):833-838.

34. Nickel MK, Loew TH, Pedrosa Gil F. Aripiprazole in treatment of borderline patients, part II: an 18-month follow-up. Psychopharmacology (Berl). 2007;191(4):1023-1026.

35. Coccaro E, Kavoussi R. Fluoxetine and impulsive aggressive behavior in personality disordered subjects. Arch Gen Psychiatry. 1997;54:1081-1088.

36. Kallioniemi H, Syvalahti E. Citalopram, a specific inhibitor of serotonin reuptake, in treatment of psychotic and borderline patients. Nord J Psychiatry. 1993;47(suppl 28):79-84.

37. Kavoussi R, Liu J, Coccaro E. An open trial of sertraline in borderline personality disordered patients with impulsive aggression. J Clin Psychiatry. 1994;55:137-141.

38. FDA public health advisory: suicidality in children and adolescents being treated with antidepressant medications. Silver Spring, MD: U.S. Food and Drug Administration; October 15, 2004. Available at: http://www.fda.gov/cder/drug/antidepressants/SSRIPHA200410.htm. Accessed March 18, 2009.

39. Medication guide: about using antidepressants in children and teenagers. Silver Spring, MD: U.S. Food and Drug Administration; 2005. Available at: http://www.fda.gov/cder/drug/antidepressants/MG_template.pdf. Accessed March 18, 2009.